Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas.
This article is protected by copyright. All rights reserved.
PMID: 31206589 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Dumont M, Ram-Wolff C, Roelens M, Brice P, de Latour RP, Battistella M, Madelaine I, Delyon J, Herms F, Bouaziz JD, Moins-Teisserenc H, Lebbé C, Bagot M, de Masson A Tags: Br J Dermatol Source Type: research
More News: Cutaneous T cell lymphoma | Dermatology | Lymphoma | Skin | Stem Cell Therapy | Stem Cells | T-cell Lymphoma | Transplants | Treanda | UK Health